Table 1.
Self‐controlled case series (SCCS) | Self‐controlled risk interval (SCRI) | |
---|---|---|
Typical uses | Safety of drugs or vaccines on acute‐onset outcomes | Mainly used to study safety of vaccines on acute‐onset outcomes |
Who’s included | Cases. Patients with the outcome during the study period. Never‐treated patients can be included to contribute to the estimation of time‐varying confounder effects | Exposed cases. Patients with the outcome and the exposure during the study period. |
Study period | Typically calendar year(s) | Time immediately surrounding an exposure event. |
Design | Incidence during risk interval compared to that during baseline time. All time that isn’t part of a risk interval (or a pre‐risk or washout interval, if used) is included as baseline time. | Incidence during risk interval compared to that during control interval. Control interval is typically short. |
Advantage | Greater power than SCRI. All time outside risk periods (and washout + pre‐risk periods) is used as baseline time | Less susceptible to time‐varying confounding than SCCS |
Disadvantage | More susceptible to time‐varying confounding than SCRI due to longer study period. Must be handled through adjustment. | Less power than SCCS |
This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.